Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Almirall Company

ALM.MC
ES0157097017
A0MU8Y

Price

9.06
Today +/-
+0
Today %
+0 %
P

Almirall stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Almirall stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Almirall stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Almirall stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Almirall's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Almirall Stock Price History

DateAlmirall Price
10/11/20249.06 undefined
10/10/20249.06 undefined
10/9/20249.08 undefined
10/8/20249.12 undefined
10/7/20249.14 undefined
10/4/20249.15 undefined
10/3/20249.12 undefined
10/2/20248.98 undefined
10/1/20249.02 undefined
9/30/20248.74 undefined
9/27/20248.85 undefined
9/26/20248.82 undefined
9/25/20248.65 undefined
9/24/20248.56 undefined
9/23/20248.42 undefined
9/20/20248.39 undefined
9/19/20248.56 undefined
9/18/20248.51 undefined
9/17/20248.50 undefined
9/16/20248.53 undefined

Almirall Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Almirall, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Almirall from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Almirall’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Almirall. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Almirall’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Almirall’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Almirall’s growth potential.

Almirall Revenue, EBIT and net profit per share

DateAlmirall RevenueAlmirall EBITAlmirall Net Income
2028e1.46 B undefined176.13 M undefined188.01 M undefined
2027e1.32 B undefined141.26 M undefined151.5 M undefined
2026e1.21 B undefined155.06 M undefined144.21 M undefined
2025e1.1 B undefined109.46 M undefined98.45 M undefined
2024e984.86 M undefined65.08 M undefined51.68 M undefined
2023894.52 M undefined40.42 M undefined-38.47 M undefined
2022863.25 M undefined54.62 M undefined4.28 M undefined
2021827.2 M undefined102.39 M undefined-40.86 M undefined
2020807.43 M undefined103.06 M undefined74.28 M undefined
2019855.34 M undefined107.94 M undefined105.91 M undefined
2018756.93 M undefined56.56 M undefined77.67 M undefined
2017639.38 M undefined-54.58 M undefined-303.96 M undefined
2016764.36 M undefined62.23 M undefined75.48 M undefined
2015684.99 M undefined83.14 M undefined131.83 M undefined
2014786.4 M undefined-2.6 M undefined448.4 M undefined
2013692.9 M undefined6.3 M undefined-33.7 M undefined
2012682.9 M undefined55.3 M undefined76.3 M undefined
2011873.1 M undefined96.9 M undefined84.2 M undefined
20101 B undefined154.4 M undefined118.6 M undefined
20091.03 B undefined179.1 M undefined151.5 M undefined
20081.06 B undefined165.8 M undefined136.1 M undefined
2007917.4 M undefined134.1 M undefined131.2 M undefined
2006854.1 M undefined115.4 M undefined147.3 M undefined
2005798.4 M undefined128.4 M undefined117.7 M undefined
2004745.2 M undefined108.7 M undefined92.6 M undefined

Almirall Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.750.80.850.921.061.0310.870.680.690.790.680.760.640.760.860.810.830.860.890.981.11.211.321.46
-7.117.027.3815.16-2.18-3.00-12.87-21.881.4713.58-12.9811.70-16.3618.3113.10-5.612.484.353.5910.0711.5910.388.9110.61
72.0871.6871.7871.6573.3972.0272.6573.2069.5074.7178.2478.0778.6672.9378.5777.4378.5679.0878.9176.29-----
53757261365777574472863947451761553460146659466263465468168200000
10812811513416517915496556-28362-5456107103102544065109155141176
14.5016.0413.4714.6115.6317.3315.3711.008.060.87-0.2512.138.12-8.457.4112.5112.7612.336.264.476.619.9312.7910.6812.05
921171471311361511188476-3344813175-3037710574-404-385198144151188
-27.1725.64-10.883.8211.03-21.85-28.81-9.52-143.42-1,457.58-70.76-42.75-504.00-125.4136.36-29.52-154.05-110.00-1,050.00-234.2192.1646.944.8624.50
-------------------------
-------------------------
183.9183.9183.9171.5175.5175.5175.5175.5171.8173.7173.6177.19181.3181.3183.5182.74183.27184.41184.53196.9900000
-------------------------
Details

Keystats

Revenue and Growth

The Almirall Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Almirall is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
                                       
323.3518.7421.4190186.1259.7312.9228.952.389.2754.4868466.71280.2386.27117.29165.67207.39248.82388.09
90.493.9100.181.383.497.784.688.180.891.8105.796.83124.884.48125.11156.2895.47104.91108.39109.01
34.944.845.16448.943.236.841.376.545.816091.7451.3662.94106.5786.7288.4756.8150.6938.03
80.593.794.6112.9112.597.787.993.292.497.78187.1291.0483.7492.33106.42130.15118.63130.1167.53
13.22.33.54.45.75.97.18.510.16.23.394.653.984.099.99.9911.5314.7216.01
0.530.750.660.450.440.50.530.460.310.331.111.150.740.520.410.480.490.50.550.72
134.8147.3151.5179.3175.7169.1154.8152.1157161.3132.1127.8132.3128.32115.24135.69132.87137.45162.7184.3
220.69054.36.33.910.810.28.58.823.3179.2180.59194.44191.96142.32103.1886.5280.534.6622.88
0000000000000000059.8920.820
0.050.070.090.380.340.350.380.350.360.60.440.410.990.731.121.141.010.920.90.95
404047.3274.3273.5272.7271.9271.1270.3336.2338.8347.31432.77341.82315.97315.97315.97315.97315.97315.97
86.297.2112.4144.2165.3173.6189213.1251.4322.1338.7316.88327.48268.68280.4269.32256.48192.5182.97181.76
0.530.450.450.990.960.981.0111.051.441.431.392.081.661.981.961.81.71.621.66
1.061.21.111.441.41.481.541.461.361.772.542.532.822.182.392.442.292.22.172.37
                                       
21.521.51919.919.919.919.919.920.520.820.820.7520.7520.7520.8620.9521.3721.5721.7825.13
848461166.8166.8166.8166.8166.8194.4219.9219.9219.89219.89219.89229.95241.01273.89295.79317.32545.87
0.690.790.680.390.470.570.640.670.720.621.061.180.08-0.30.951.021.060.990.960.88
0.010.010.01-0-0.01-0.01-0-0-0.010.030.040.041.21.19-0.01-0.01-0.05-0.020.020.01
0000000002.52.52.542.542.5400002.542.54
0.80.90.760.570.650.750.820.850.920.891.341.461.521.131.191.281.31.291.321.47
125.1138.5143.1142.7154.4142.79687.8187.6213.5224.2231.36286.57273.36194.6262.87165.96208.32197.82270.61
0000000032.3112.662.542.5847.0329.128.2927.1130.3833.9933.1732.55
54.76963.169.284.795.2117.2123.52642.260.11037.9945.9525.8215.5724.720.2426.9230.71
000000003.72.310.613.7800000000
5.47.35.862.968.869.9148.4202.2027.53.83.84003.2610.98253.5218.4516.7117.21
185.2214.8212274.8307.9307.8361.6413.5249.6398.1361.2301.56371.59348.41251.97316.53474.56280.99274.61351.08
0.100402.824418414200253.9316.1315.88317.19250522.67484.79237.83373.85387.16386.04
33.247.848.479.382.689.183.27671.8135.2126.7125.42233.4140.16134.88127.54117.3875.8577.2571.92
41.141.390.6108.7108.9151.1130.6112.3111.297.1396.8326.91376.07304.2288.24230.74158.38125.0189.95102.55
74.489.1139590.8435.5424.2355.8188.3183486.2839.6768.21926.66694.36945.78843.07513.59574.71554.36560.51
0.260.30.350.870.740.730.720.60.430.881.21.071.31.041.21.160.990.860.830.91
1.061.21.111.441.41.481.541.461.361.772.542.532.822.182.392.442.292.142.152.38
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Almirall provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Almirall's financial health and stability.

Assets

Almirall's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Almirall must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Almirall after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Almirall's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
1021371451291441711197248-8948217292-3217412879-931-17
29302836636461636869847410010390129123119120124
00000000000000000000
13-1723181335-15-314612-416-10-211067-1027-21-71
8-8-34-411-99-3-5074122-82-77245-32-49-79952557
478142500075141515182666910
262127-142040313617855188-51826-23613
15414116417923326117410011267646170105614327611223315593
-40-71-60-287-23-70-92-38-79-63-69-26-82-69-598-135-76-71-116-159
-348227-531-14-55-85-27-76-307-2-5-457-67-607-144-23-57-68-122
515488-2439158113-2436721-3751-9-953134736
00000000000000000000
-41-1460-145-5736-90-20228137-10-73296-62-25-412-17-16
00-25010600000000000-102950197
-34-29-289120-222-132-36-156-21227620-51-49-125270-100-40-134-45168
--6.00-7.00-26.00-24.00-23.00-17.00-19.00-9.00-3.00-17.00-15.00-15.00-18.00-2.00-12.00-13.00-5.00-15.00-10.00
-30-24-30-420-52-52-55-47-100-35-33-33-22-24-2-11-12-2
84195-97-231-37353-84-17636665113-401-186-19331484141139
113.969.9103.8-108.5209.419181.761.733.23.4577.5144.1122.97-62.96-455.68141.0636.23162.738.62-65.82
00000000000000000000

Almirall stock margins

The Almirall margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Almirall. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Almirall.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Almirall's sales revenue. A higher gross margin percentage indicates that the Almirall retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Almirall's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Almirall's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Almirall's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Almirall. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Almirall's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Almirall Margin History

Almirall Gross marginAlmirall Profit marginAlmirall EBIT marginAlmirall Profit margin
2028e76.25 %12.06 %12.87 %
2027e76.25 %10.7 %11.48 %
2026e76.25 %12.79 %11.9 %
2025e76.25 %9.97 %8.97 %
2024e76.25 %6.61 %5.25 %
202376.25 %4.52 %-4.3 %
202278.94 %6.33 %0.5 %
202179.11 %12.38 %-4.94 %
202078.64 %12.76 %9.2 %
201977.5 %12.62 %12.38 %
201878.52 %7.47 %10.26 %
201772.94 %-8.54 %-47.54 %
201678.7 %8.14 %9.87 %
201577.99 %12.14 %19.25 %
201478.2 %-0.33 %57.02 %
201374.74 %0.91 %-4.86 %
201269.51 %8.1 %11.17 %
201173.27 %11.1 %9.64 %
201072.68 %15.41 %11.84 %
200972.03 %17.33 %14.66 %
200873.48 %15.7 %12.89 %
200771.66 %14.62 %14.3 %
200671.82 %13.51 %17.25 %
200571.64 %16.08 %14.74 %
200472.14 %14.59 %12.43 %

Almirall Stock Sales Revenue, EBIT, Earnings per Share

The Almirall earnings per share therefore indicates how much revenue Almirall has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Almirall earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Almirall's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Almirall’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Almirall's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Almirall Revenue, EBIT and net profit per share

DateAlmirall Sales per ShareAlmirall EBIT per shareAlmirall Earnings per Share
2028e6.84 undefined0 undefined0.88 undefined
2027e6.18 undefined0 undefined0.71 undefined
2026e5.68 undefined0 undefined0.68 undefined
2025e5.14 undefined0 undefined0.46 undefined
2024e4.61 undefined0 undefined0.24 undefined
20234.54 undefined0.21 undefined-0.2 undefined
20224.68 undefined0.3 undefined0.02 undefined
20214.49 undefined0.56 undefined-0.22 undefined
20204.41 undefined0.56 undefined0.41 undefined
20194.68 undefined0.59 undefined0.58 undefined
20184.12 undefined0.31 undefined0.42 undefined
20173.53 undefined-0.3 undefined-1.68 undefined
20164.22 undefined0.34 undefined0.42 undefined
20153.87 undefined0.47 undefined0.74 undefined
20144.53 undefined-0.01 undefined2.58 undefined
20133.99 undefined0.04 undefined-0.19 undefined
20123.97 undefined0.32 undefined0.44 undefined
20114.97 undefined0.55 undefined0.48 undefined
20105.71 undefined0.88 undefined0.68 undefined
20095.89 undefined1.02 undefined0.86 undefined
20086.02 undefined0.94 undefined0.78 undefined
20075.35 undefined0.78 undefined0.77 undefined
20064.64 undefined0.63 undefined0.8 undefined
20054.34 undefined0.7 undefined0.64 undefined
20044.05 undefined0.59 undefined0.5 undefined

Almirall business model

The company Almirall SA is a globally operating pharmaceutical company headquartered in Barcelona, Spain. Founded in 1943 by Antonio Gallardo Ballart, the company has since become one of the leading companies in the field of dermatology and respiratory diseases. Almirall specializes in the development, manufacturing, and marketing of medications used in the treatment of skin conditions such as psoriasis or eczema, as well as respiratory diseases such as asthma or chronic bronchitis. The company focuses on close collaboration with doctors and patients to achieve the best possible therapeutic success. Almirall's business model is based on collaboration with other pharmaceutical companies to develop and bring innovative medications to the market. The company has its own research and development departments and also conducts clinical trials to test the safety and efficacy of new medications. Additionally, Almirall operates its own network of distribution and marketing partners to distribute its products worldwide. Almirall is organized into three divisions: dermatology, respiratory diseases, and other therapeutic areas. The dermatology division includes the development and marketing of medications for the treatment of skin conditions such as psoriasis and eczema. Some examples of products in this division are Skilarence, a medication for the treatment of moderate to severe psoriasis, and Kigozi, a topical medication for the treatment of atopic dermatitis. The respiratory diseases division includes the development and marketing of medications for the treatment of asthma and chronic bronchitis. The company offers a wide range of medications in this area that can be used in inhalation or tablet therapy. Some of the well-known products in this division are Alvesco, an inhaled corticosteroid for the treatment of asthma, and Ebastel, a medication for the treatment of allergic reactions. In other therapeutic areas, Almirall is involved in the development of new medications for the treatment of diseases such as ulcerative colitis or schizophrenia. For example, the company has developed Sativex, a cannabis-based medication for the treatment of multiple sclerosis-related spasticity, which is already approved in several countries. Throughout its history, Almirall has received numerous awards and recognition, including for the development of innovative medications and its work in the field of sustainability and corporate social responsibility. Through its commitment to research and development and collaboration with other pharmaceutical companies, Almirall will continue to play an important role in the global pharmaceutical industry market. Almirall is one of the most popular companies on Eulerpool.com.

Almirall SWOT Analysis

Strengths

Almirall SA possesses several key strengths that contribute to its competitive advantage in the market. These include:

  • Strong brand reputation and recognition globally
  • Diverse portfolio of innovative pharmaceutical products
  • Strong research and development capabilities
  • Robust distribution network and strong partnerships

Weaknesses

Despite its strengths, Almirall SA also faces certain weaknesses that may hinder its growth and performance. These include:

  • Overdependence on a limited number of key products
  • Relatively small market share compared to industry leaders
  • Vulnerability to changes in government regulations
  • Higher production costs compared to some competitors

Opportunities

Almirall SA has various opportunities in the market that it can capitalize on for future growth. These opportunities include:

  • Increasing global demand for dermatological and respiratory treatments
  • Expansion into emerging markets with rising healthcare spending
  • Growing trend of research and development collaborations in the industry
  • Introduction of new drugs and therapies targeting unmet medical needs

Threats

Almirall SA also faces several threats that may pose challenges to its business operations and profitability. These threats include:

  • Intense competition from well-established pharmaceutical companies
  • Increase in generic drug manufacturing and pricing pressure
  • Rapid advancements in technology impacting the industry
  • Stringent regulations and requirements for product approvals

Almirall Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Almirall historical P/E ratio, EBIT multiple, and P/S ratio

Almirall shares outstanding

The number of shares was Almirall in 2023 — This indicates how many shares 196.992 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Almirall earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Almirall's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Almirall’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Almirall's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Almirall dividend history and estimates

In 2023, Almirall paid a dividend amounting to 0.18 EUR. Dividend means that Almirall distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Almirall provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Almirall’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Almirall's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Almirall Dividend History

DateAlmirall Dividend
2028e0.18 undefined
2027e0.18 undefined
2026e0.18 undefined
2025e0.18 undefined
2024e0.18 undefined
20230.18 undefined
20220.19 undefined
20210.19 undefined
20200.2 undefined
20190.2 undefined
20180.18 undefined
20170.19 undefined
20160.19 undefined
20150.2 undefined
20130.15 undefined
20120.17 undefined
20110.26 undefined
20100.31 undefined
20090.29 undefined
20080.29 undefined

Almirall dividend payout ratio

In 2023, Almirall had a payout ratio of 294.97%. The payout ratio indicates the percentage of the company's profits that Almirall distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Almirall represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Almirall could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Almirall's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Almirall Payout Ratio History

DateAlmirall Payout ratio
2028e434.75 %
2027e421.53 %
2026e389.89 %
2025e492.85 %
2024e381.85 %
2023294.97 %
2022801.72 %
2021-83.5 %
202048.85 %
201934.33 %
201842.43 %
2017-11.06 %
201644.55 %
201526.24 %
2014294.97 %
2013-78.6 %
201237.62 %
201154.74 %
201045.77 %
200933.8 %
200837.26 %
2007294.97 %
2006294.97 %
2005294.97 %
2004294.97 %
Unfortunately, there are currently no price targets and forecasts available for Almirall.

Almirall latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.03 0.04  (27.95 %)2024 Q2
3/31/20240.01 0.03  (196.77 %)2024 Q1
9/30/2023-0.03 0.01  (132.96 %)2023 Q3
6/30/20230.03 0.02  (-30.69 %)2023 Q2
3/31/20230.14 0.04  (-71.71 %)2023 Q1
6/30/20220.05 0.04  (-19.55 %)2022 Q2
3/31/20220.06 0.11  (81.4 %)2022 Q1
12/31/20210.02 0.11  (373.06 %)2021 Q4
9/30/20210.07 0.01  (-82.3 %)2021 Q3
6/30/20210.1 0.08  (-23.5 %)2021 Q2
1
2
3
4
5
...
6

Eulerpool ESG Scorecard© for the Almirall stock

Eulerpool World ESG Rating (EESG©)

69/ 100

🌱 Environment

99

👫 Social

83

🏛️ Governance

26

Environment

Scope 1 - Direct Emissions
7,487
Scope 2 - Indirect emissions from purchased energy
4,543
Scope 3 - Indirect emissions within the value chain
145,409
Total CO₂ emissions
12,030
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees54
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Almirall shareholders

%
Name
Stocks
Change
Date
58.99483 % Gallardo Ballart family125,935,66703/29/2024
4.97145 % Norbel Invesrsiones, S.L.10,612,50503/29/2024
4.87316 % Wellington Management Company, LLP10,402,68003/29/2024
1.35166 % Caixabank Asset Management SGIIC, S.A.U.2,885,38102/29/2024
1.21920 % The Vanguard Group, Inc.2,602,6193,4463/31/2024
1.02284 % Santander Asset Management2,183,440734,99912/31/2023
0.98466 % Norges Bank Investment Management (NBIM)2,101,937613,74212/31/2023
0.82150 % Oddo BHF Asset Management S.A.S1,753,655290,1041/31/2024
0.80502 % Cobas Asset Management, SGIIC, SA1,718,473501,5332/29/2024
0.53148 % Dimensional Fund Advisors, L.P.1,134,55546,9133/31/2024
1
2
3
4
5
...
10

Almirall Executives and Management Board

Mr. Carlos Gallardo Pique50
Almirall Executive Chairman of the Board, Chief Executive Officer (since 2014)
Compensation 443,000
Dr. Thomas McKillop80
Almirall First Vice Chairman of the Board, Other External Director (since 2007)
Compensation 170,000
Mr. Enrique De Leyva Perez63
Almirall Lead Independent Director
Compensation 130,000
Dr. Seth Orlow64
Almirall Independent Director
Compensation 130,000
Mrs. Eva-Lotta Coulter63
Almirall Independent Director
Compensation 125,000
1
2
3
4
...
5

Most common questions regarding Almirall

What values and corporate philosophy does Almirall represent?

Almirall SA represents values of innovation, integrity, and excellence in the pharmaceutical industry. The company is committed to improving patients' lives by developing and providing effective and safe medical solutions. Almirall SA strives for scientific advancement and collaboration to address unmet medical needs. With a strong corporate philosophy focused on patient-centricity and sustainability, Almirall SA aims to deliver high-quality healthcare products and services worldwide. Through its dedication to research and development, this global pharmaceutical company seeks to make a positive impact on patients, healthcare professionals, and society as a whole.

In which countries and regions is Almirall primarily present?

Almirall SA is primarily present in various countries and regions worldwide. The company has a significant presence in Europe, including Spain, where it is headquartered. Additionally, Almirall SA operates in several countries across the Americas, including Mexico, Brazil, and Colombia. The company also has a growing presence in Asia, particularly in China and Japan. Almirall SA's global reach enables it to serve a diverse customer base and leverage different market opportunities.

What significant milestones has the company Almirall achieved?

Almirall SA has achieved several significant milestones in its corporate history. Over the years, the company has successfully developed and marketed innovative pharmaceutical products. Notably, Almirall SA has gained regulatory approvals for a range of therapeutic solutions, such as dermatology treatments and respiratory medicines. The company has also expanded its global presence and entered into strategic partnerships to enhance its research and commercial capabilities. Almirall SA continues to strive for excellence in the healthcare industry, focusing on the development of novel therapies to improve patients' lives and maintain its position as a leading pharmaceutical company.

What is the history and background of the company Almirall?

Almirall SA, a leading pharmaceutical company, has a rich history and a strong background. Founded in 1943 in Barcelona, Spain, Almirall has been dedicated to improving people's health and well-being for over 75 years. The company specializes in researching, developing, manufacturing, and marketing innovative medicines and healthcare solutions worldwide. With a commitment to scientific excellence and a customer-centric approach, Almirall has established itself as a trusted name in the pharmaceutical industry. Continuously expanding its product portfolio and collaborating with valued partners, Almirall strives to meet the evolving needs of patients and healthcare professionals, driving advancements and reshaping the future of healthcare.

Who are the main competitors of Almirall in the market?

The main competitors of Almirall SA in the market include prominent pharmaceutical companies such as AstraZeneca, Novartis, Johnson & Johnson, and GlaxoSmithKline.

In which industries is Almirall primarily active?

Almirall SA is primarily active in the pharmaceutical industry.

What is the business model of Almirall?

The business model of Almirall SA focuses on the pharmaceutical industry. Almirall SA is a global biopharmaceutical company that specializes in the research, development, and commercialization of innovative medicines. They operate primarily in the fields of dermatology, gastroenterology, and respiratory diseases, offering a diversified portfolio of pharmaceutical products. Almirall SA aims to meet patient needs by delivering high-quality and effective medicines while maintaining a strong commitment to research and development. Through strategic partnerships and collaborations, Almirall SA strives to improve the health and well-being of people worldwide with their innovative solutions.

What is the P/E ratio of Almirall 2024?

The Almirall P/E ratio is 34.54.

What is the P/S ratio of Almirall 2024?

The Almirall P/S ratio is 1.81.

What is the Quality Investing of Almirall?

The Quality Investing for Almirall is 3/10.

What is the revenue of Almirall 2024?

The expected Almirall revenue is 984.86 M EUR.

How high is the profit of Almirall 2024?

The expected Almirall profit is 51.68 M EUR.

What is the business model of Almirall

Almirall SA is a pharmaceutical company based in Spain. The company focuses on researching and developing medications for the treatment of respiratory and dermatology conditions, as well as pain and inflammatory diseases.

What is the Almirall dividend?

Almirall pays a dividend of 0.19 EUR distributed over payouts per year.

How often does Almirall pay dividends?

The dividend cannot currently be calculated for Almirall or the company does not pay out a dividend.

What is the Almirall ISIN?

The ISIN of Almirall is ES0157097017.

What is the Almirall WKN?

The WKN of Almirall is A0MU8Y.

What is the Almirall ticker?

The ticker of Almirall is ALM.MC.

How much dividend does Almirall pay?

Over the past 12 months, Almirall paid a dividend of 0.18 EUR . This corresponds to a dividend yield of about 2.03 %. For the coming 12 months, Almirall is expected to pay a dividend of 0.18 EUR.

What is the dividend yield of Almirall?

The current dividend yield of Almirall is 2.03 %.

When does Almirall pay dividends?

Almirall pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Almirall?

Almirall paid dividends every year for the past 14 years.

What is the dividend of Almirall?

For the upcoming 12 months, dividends amounting to 0.18 EUR are expected. This corresponds to a dividend yield of 2.01 %.

In which sector is Almirall located?

Almirall is assigned to the 'Health' sector.

Wann musste ich die Aktien von Almirall kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Almirall from 6/12/2024 amounting to 0.184 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Almirall pay the last dividend?

The last dividend was paid out on 6/12/2024.

What was the dividend of Almirall in the year 2023?

In the year 2023, Almirall distributed 0.186 EUR as dividends.

In which currency does Almirall pay out the dividend?

The dividends of Almirall are distributed in EUR.

All fundamentals about Almirall

Our stock analysis for Almirall Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Almirall Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.